Management of Thiazide-Induced Hyponatremia

Diagnosis and Treatment

When hyponatremia is detected in a patient taking HCTZ, the American Heart Association recommends discontinuing the thiazide diuretic, implementing fluid restriction to 1000 mL/day for moderate to severe hyponatremia, providing cation repletion as needed, and monitoring serum sodium levels every 4-6 hours during active correction, with a target correction rate of 4-6 mmol/L in 24 hours, not exceeding 8 mmol/L in 24 hours to avoid osmotic demyelination syndrome 1

For patients who require a diuretic after HCTZ-induced hyponatremia, the American College of Cardiology suggests considering loop diuretics, which have a different mechanism of action, and using a loop diuretic instead of thiazide diuretics if eGFR is <30 mL/min/m² 2
The European Society of Cardiology recommends that for patients requiring a thiazide-type diuretic, chlorthalidone or indapamide may be preferable over HCTZ for hypertension management, with moderate evidence strength 3

To prevent thiazide-induced hyponatremia, the National Institute for Health and Care Excellence advises using caution when prescribing HCTZ to elderly patients with low body mass, monitoring serum electrolytes regularly, especially in high-risk patients, considering lower doses in susceptible individuals, and educating patients about symptoms of hyponatremia and when to seek medical attention, with low evidence strength 1